2019-20 Transactions Raised
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Annual Report 2018-19 80Th Year Contents
Accelerating focussed growth Integrated Annual Report 2018-19 80th Year Contents Integrated Report Deep innovation expertise to harness the 01-57 best of science and serve the society. 01 Company Overview A passion to consistently push beyond 06 Our Diversified Science Led Portfolio 08 Performance Highlights for FY 2018-19 existing limits and rise above. 10 Board of Directors Combine innovation and passion with scale 12 Management Team and accelerated growth happens. 13 MD & CEO's Message 14 Integrated Value Chain This is how Tata Chemicals has emerged to be one of the world’s most reputed brands, revolutionising the 16 Business Model Explaining the Interlinkage of Capitals industry segments it has operated in its 18 Our Formula for Accelerating 80-year journey. Focussed Growth As we continue to nurture our inherent strengths, 21 Managing Risks, Maximising Returns we are undertaking many initiatives to accelerate our 24 Listening to and Engaging growth in focussed areas. with the Stakeholders 25 Addressing Material Issues Our multi-pronged strategy of customer-centric 26 Basic Chemistry Business product development and expansion into white spaces in our Consumer Products Business and capacity 32 Consumer Products Business augmentation programmes in our Specialty Products 38 Specialty Chemicals Business Business has laid a strong foundation for growth. 45 Intensifying Focus on Health & Safety Aligning our organisational structure and strategies 46 Innovating for a Better World with the revised segment reporting and the exit from 48 Growing Together non-core businesses has simplified our portfolio and are 50 Our Commitment to driving stronger synergies. Strong innovation drive is Sustainable Growth enabling us to tap the emerging areas and 53 Corporate Social Responsibility nurture the newly-seeded portfolio. -
Delivering Today. Innovating for Tomorrow
DELIVERING TODAY. INNOVATING FOR TOMORROW. INVESTING IN OUR FUTURE. CUSTOMER NEWS NOVEMBER 2017 A ENTERPRISE Following a strategic review in 2011, TCE has undertaken major change in our business over the last few years. From being primarily a soda ash business, we A message from our shareholder have transformed into a broad diversified soda ash, sodium bicarbonate and salt business delivering reliable high quality products into increasingly diverse markets. “Our team at Tata Chemicals Europe have worked We have built a strong and sustainable cost base, made possible by a hugely engaged tirelessly to deliver a robust and passionate workforce. We have acquired British Salt Limited, built the first stand- and diverse business. On alone sodium bicarbonate plant of its kind, established a major soda ash import facility as behalf of the Shareholder a virtual factory to support our indigenous manufacturing plant in Northwich, invested we are excited to support heavily in new supply chain solutions, and implemented a major package of business and the investment plans for the coming 5 process improvements. years across TCE’s soda ash, bicarb and salt businesses. Next year will be 150 years of Significantly we have been able to take control of our own energy supplies for our soda Tata and as we look forward to that event, ash and sodium bicarbonate businesses by acquiring from EoN the gas-fired CHP plant we wish to thank you very much for your at our Winnington site. Having the CHP plant and our soda ash and sodium bicarbonate continued support of our TCE business.” facilities under common ownership and control has driven far greater efficiency, cost R Mukundan, Managing Director control and reliability for these businesses. -
Register of GDP Sites 2019
Register of GDP Sites 2019 Updated 16 August 2019 There are other sites authorised for wholesale dealing of veterinary medicinal products which do not appear on this register. These sites wholesale deal in both human and veterinary medicinal products and can be found on the MHRA section of GOV.UK: https://www.gov.uk/government/publications/human-and-vetinary-medicines- register-of-licensed-wholesale-distribution-sites-december-2014 Register of Authorised Wholesale Dealer Sites Authorisation Holder: WDA33618 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0415 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0010 ABBEYVET LLP SHERBURN ENTERPRISE PARK, SHERBURN IN ELMET, LEEDS, WEST YORKSHIRE, LS25 6NB Authorisation Holder: WDA8599 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN SITE ID: S0015 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN Authorisation Holder: WDA5097 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0456 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0525 CVS GROUP PLC CVS HOUSE, OWEN ROAD, DISS, NORFOLK, IP22 4ER Authorisation Holder: WDA5030 ALBERT E JAMES & SON LIMITED BARROW MILL BARROW STREET, BARROW GURNEY, BRISTOL, BS48 3RU SITE ID: S0303 ALBERT E JAMES & -
United States Securities and Exchange Commission Form 10-K Shire Pharmaceuticals Group
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1999 អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) N.A. East Anton, Andover, Hampshire SP10 5RG England (Address of principal executive offices) (Zip Code) 44 1264 333455 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depository Shares, each representing Nasdaq National Market 3 Ordinary Shares, 5 pence nominal value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ፤ No អ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant's knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K. -
Listing of Global Companies with Ongoing Government Activity
COMPANY LINE OF BUSINESS TICKER A & A BIOTECHNOLOGY S C ADAM BURKIEWICZ MIKOLAJ BURKIEWICZ PHARMACEUTICAL PREPARATIONS A & A GLOBAL INDUSTRIES, INC. AUTOMATIC VENDING MACHINES, NSK A & J ENTERPRISES PHARMACEUTICAL PREPARATIONS A & S INTERNATIONAL 2000 S.R.L. PHARMACEUTICAL PREPARATIONS A & S PHARMACEUTICAL CORP. PHARMACEUTICAL PREPARATIONS A & T MARKETING INC. COMPUTER INTEGRATED SYSTEMS DESIGN, NSK A & T SYSTEMS, INC. TELEPHONE COMMUNICATION, EXCEPT RADIO A & Z PHARMACEUTICAL INC. PHARMACEUTICAL PREPARATIONS A A INTERNATIONAL PHARMACEUTICAL PREPARATIONS A AND V, INC. BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC A AROGYA HARBALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A B ENTERPRISES PHARMACEUTICAL PREPARATIONS A B I HERBAL PRODUCTS MEDICINALS AND BOTANICALS, NSK A B S REMEDIES PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A BEAT FOR YOUR FEET, INC. COIN-OPERATED LAUNDRIES AND CLEANING, NSK A BUCKHEAD BUS COMPANY LOCAL PASSENGER TRANSPORTATION, NEC A C C VIEIRA PROTESE ME MEDICINALS AND BOTANICALS, NSK A C CONSULTING PHARMACEUTICAL PREPARATIONS A C E DIAGNOSTICS & BIOTECH LIMITED PHARMACEUTICAL PREPARATIONS A C E PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A C PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A CUT ABOVE LANDSCAPE LAWN AND GARDEN SERVICES A D C O MARKETING INC NONDURABLE GOODS, NEC, NSK A G HERBALS PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A G PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A H C PHARMACAL, INC PHARMACEUTICAL PREPARATIONS A H SYSTEMS INC INSTRUMENTS TO MEASURE ELECTRICITY A HOUSE OF AYURVEDIC -
CRR 446/2002 a Study of the Provision of Health and Safety Information in the Annual Reports of the Top UK Companies
HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Prepared by System Concepts Ltd for the Health and Safety Executive CONTRACT RESEARCH REPORT 446/2002 HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Laura Peebles, Ansgar Kupper and Tanya Heasman System Concepts Ltd 2 Savoy Court Strand London WC2R 0EZ This report details the findings of a research project to investigate the quality and quantity of health and safety information found in the annual reports of the top UK companies. At present, publicly listed companies are not legally required to include health and safety matters in their annual reports. The current Health and Safety Commission (HSC) Strategy Statement, however, contains an action point which focuses on public reporting of health and safety issues by larger companies. The aim is to promote the reporting of health and safety information in company annual reports and to provide guidance that would allow reporting of such information to a common standard. To assist the HSC with this strategy, System Concepts were commissioned by the Health and Safety Executive (HSE) to undertake an investigation of the provision of health and safety information in company annual reports. The study comprised a series of steps. The main objectives of the study were: i) To determine the current level of reporting of health and safety issues in annual reports of the top UK companies ii) To determine the quality of health and safety information reported. -
Rape Research
Rape Research After scene 2, in Paulson‘s Tavern, Tara is left behind whilst it empties out. This is the perfect setting for Danni to tranquilise her with a date rape drug. This is quite a strong subject, and I felt like the whole group should put more research and get a greater understanding, so we know how to deal with the situation and portray it through our performance. Personally, I have never known anyone who has experienced this situation before, so to ensure that I would create a believable performance and reaction, I needed to get a greater understanding and look at interviews, dramas and information about date rape and the affect it has on people‘s lives. BBC Health – Rohypnol http://www.bbc.co.uk/health/physical_health/conditions/rohypnol.shtml What is Rohypnol? Rohypnol is the brand name of a medicine called flunitrazepam, and is one of the benzodiazepine class of sedative or tranquilizer drugs, of which ‗Valium‘ or diazepam is perhaps the best known. Rohypnol or flunitrazepam is 10 times more potent than diazepam. In the UK the drug is no longer used in the NHS but may be available on private prescription for those who need it (although it‘s generally felt that there are better alternatives). Its legal status in the UK is a class C drug, which means that it‘s illegal to possess flunitrazepam without a prescription. It‘s not legally available in the US, but as it is still made in some countries an illegal trade continues. Rohypnol rose to prominence as the date rape drug because it was colourless, odourless, tasteless and easily dissolved - ideal for spiking drinks undetected - and causes sedation or euphoria in approximately 20 to 30 minutes. -
Chapter-I Introduction
CHAPTER-I INTRODUCTION 1 INTRODUCTION Tata Group Type Private Industry Conglomerate Founded 1868 Founder(s) Jamsetji Tata Bombay,house Headquarters Mumbai, India Area served Worldwide RatanTata Key people (Chairman) Steel Automobiles Telecommunications Products Software Hotels Consumer goods 2 Revenue 319,534 crore (US$69.34 billion) Profit 8,240 crore (US$1.79 billion) Total assets US$ 52.8 billion (2009-10) Employees 396,517 (2009-10) TataSteel TataSteelEurope TataMotors TataConsultancyServices TataTechnologies TataTea Subsidiaries TitanIndustries TataPower TataCommunications TataTeleservices TataAutoCompSystemsLimited Taj Hotels Website Tata.com Tata Group Companies CMC · Tata BP Solar · Tata Coffee · Tata Chemicals · Tata Consultancy Services · Tata Elxsi · Tata Interactive Systems · Tata Motors · Tata Steel · Tata Power · Tata India-basedTea · Tata Communications · Tata Technologies Limited · Tata Teleservices · Titan Industries · Tata Voltas · The Indian Hotels Company · Trent (Westside) · Cromā 3 Brunner Mond · Jaguar Land Rover (Jaguar Cars · Land Other Rover) · Tata Daewoo Commercial Vehicle · Tata Steel Europe · Tetley · VSNL International Canada Ginger · Good Earth Teas · Tanishq · Taj Hotels · I-shakti · Tata Salt · Brands Tata Sky · Tata Indicom · Tata DoCoMo · Titan · Westside · Voltas · Virgin Mobile India Notable Jamsetji Tata · Ratanji Dadabhoy · Dorabji Tata · Nowroji People Saklatwala · J. R. D. Tata · Ratan Tata · Pallonji Mistry Bombay House is the head office of Tata Group The Tata Group is an Indian multinational conglomerate company headquartered in the Bombay House in Mumbai, India. In terms of market capitalization and revenues, Tata Group is the largest private corporate group in India. It has interests in chemicals, steel, automobiles, information technology, communication, power, beverages, and hospitality. The Tata Group has operations in more than 80 countries across six continents and its companies export products and services to 80 nations. -
Cold Chain Distribution Conference and Exhibition Enhance Temperature Management for an Efficient Supply Chain
SMi PRESENTS THE 9TH ANNUAL COLD CHAIN DISTRIBUTION CONFERENCE AND EXHIBITION ENHANCE TEMPERATURE MANAGEMENT FOR AN EFFICIENT SUPPLY CHAIN 2ND - 3RD DECEMBER 2014 | MARRIOTT REGENTS PARK, LONDON UK Sponsorship Manual www.coldchain-distribution.com “ A very well organised event. Professional team and well executed” Cold Chain Delegate 2013 9th annual Cold Chain Distribution Conference and Exhibition Drawing on 8 years of working within the Cold Chain Logistics industry, the SMi Group are delighted to announce their 9th annual Cold Chain Distribution Conference and Exhibition. Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. Benefits of Attending: ● Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate ● Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo ● Strengthen your supply chain through management and efficiency insights from Merck Serono and Genzyme ● In addition, Cold Chain Distribution -
2017-18 About This Report
59 2017-18 79th Annual Report Report Annual 79th www.linkedin.com/Company/tata-chemicals www.tcsrd.com www.twitter.com/TataChemicals www.okhai.org www.facebook.com/humantouchofchemistry www.tatanx.in www.facebook.com/TataChemicals www.tataswach.com www.tatachemicals.com www.tatasampann.com www.tatasalt.com www.humantouchofchemistry.com Fax: +91 22 6665 8144 Telephone: +91 22 6665 8282 CIN: L24239MH1939PLC002893 Mumbai - 400001 India. Homi Mody Street, Fort, Bombay House, 24, Registered Address Financial Statements Statutory Reports Transform Grow Grow Integrated Report About this report Tata Chemicals seeks to go beyond compliance in its corporate reporting. Alongside statutory declarations, this Annual Report includes non-financial information that is disclosed on a voluntary basis in accordance with the Integrated Reporting <IR> framework of International Integrated Reporting Council (IIRC). Assurance on financial statements has been provided by independent auditors B S R & Co. LLP and non- financial statements by Ernst & Young LLP. Monitoring marine turtle mortality and nesting along the Okhamandal coast Contents Integrated Report Introduction 2 Ethics 39 Highlights at a glance 3 Peoples practices 40 Company overview 4 Community 42 MD's message 6 Sustainability 46 Performance highlights 7 Risks 49 Materiality 8 Board of Directors 50 Value creation 10 Management team 52 Strategy and KPIs 12 Basis of report preparation 53 Forward looking statements 53 Consumer products Assurance notice 54 Business overview 16 Results at a glance 56 Case -
SHIRE PHARMACEUTICALS GROUP PLC (Exact Name of Registrant As Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales 98-0359573 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Hampshire International Business Park, Chineham, +44 1256 894 000 Basingstoke, Hampshire, England, RG24 8EP (Registrant’s telephone number, including area code) (Address of principal executive offices and zip code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depositary Shares, each representing 3 NASDAQ National Market Ordinary Shares 5 pence par value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K. -
University of Strathclyde Beats LBS and Oxford in Finals
Victorious University of Strathclyde repeats history at 4th UK edition of Tata Crucible Campus Quiz UK champions win a second opportunity to travel to India for the international finals, along with newcomers ESCP Europe London, 20th November 2011: The team of Anup Nair and Michael Doroszenko from The University of Strathclyde emerged as champions for the second year in a row at the 4th annual UK Tata Crucible, a major business quiz designed to encourage lateral thinking and test commercial awareness for the country’s future business leaders. The pair from Strathclyde impressed the audience and Quiz Master ‘Pickbrain’ with a confident win, fighting off a spirited challenge from the second place team of ESCP Europe and third place team of London Business School (LBS), with the championship title being decided only on the last question of the evening. Amongst this year’s special guests were Dr Ralph Speth, CEO of Jaguar Land Rover, who expressed fascination with the power of the questions and the excitement of the evening, while emphasizing the crucial role that young talent plays in the future success of companies. This year’s chief guest was Jo Johnson, MP for Orpington and former India Bureau Chief for the Financial Times. Awarding the winners with their prizes, Mr Johnson said “It is a very inspiring evening. I am just awe-struck, by not just the knowledge, the factual knowledge that our contestants had, but the ingenuity and the creativity that they displayed in all of their answers”. He urged the students to strive for excellence to achieve success and added “Keep on displaying the sheer enthusiasm for the subject matter and the creativity and ingenuity I just referred to and the world will be yours”.